Nike Inc (NKE) Stake Owned by Swoosh, LLC December 31st,

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

Nike Inc (NKE) Stake Owned by Swoosh, LLC
December 31st, 2015 - By Thomas Dobrow - 0 comments

Nike logoSwoosh, LLC recently disclosed that they own a 15.1% stake in Nike Inc (NYSE:NKE) in a Schedule 13D/A disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, December 31st. The investor owns 257,000,000 shares of the stock valued at $16,062,500,000. The filing is available through the SEC website at this link.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Meag Munich Ergo Kapitalanlagegesellschaft bought a new position in Nike during the third quarter worth $26,543,000. Saturna Capital increased its position in Nike by 1.4% in the third quarter. Saturna Capital now owns 394,670 shares of the footwear maker’s stock worth $48,533,000 after buying an additional 5,609 shares in the last quarter. Perigon Wealth Management increased its position in Nike by 1.0% in the third quarter. Perigon Wealth Management now owns 7,258 shares of the footwear maker’s stock worth $893,000 after buying an additional 73 shares in the last quarter. Finally, Gerstein Fisher increased its position in Nike by 9.7% in the third quarter. Gerstein Fisher now owns 7,758 shares of the footwear maker’s stock worth $954,000 after buying an additional 686 shares in the last quarter.

Shares of Nike Inc (NYSE:NKE) traded down 1.19% on Thursday, reaching $62.50. 6,440,889 shares of the company’s stock traded hands. The company has a market cap of $106.66 billion and a PE ratio of 30.43. Nike Inc has a 12-month low of $45.35 and a 12-month high of $68.19. The stock has a 50-day moving average price of $64.58 and a 200-day moving average price of $59.89.

Nike (NYSE:NKE) last posted its quarterly earnings results on Tuesday, December 22nd. The footwear maker reported $0.90 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.04. During the same quarter in the previous year, the company earned $0.74 earnings per share. The company earned $7.69 billion during the quarter. Nike’s revenue for the quarter was up 4.1% compared to the same quarter last year. Equities research analysts anticipate that Nike Inc will post $2.15 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Wednesday, December 9th will be paid a $0.32 dividend. This is a boost from Nike’s previous quarterly dividend of $0.28. This represents a $1.28 annualized dividend and a yield of 2.05%. The ex-dividend date is Monday, December 7th.

Several research analysts recently commented on NKE shares. BB&T Corp. raised shares of Nike from a “hold” rating to a “buy” rating and set a $74.00 price objective for the company in a report on Monday, October 19th. DA Davidson raised their price objective on shares of Nike from $70.00 to $72.50 and gave the stock a “buy” rating in a report on Thursday, October 15th. Telsey Advisory Group raised their price objective on shares of Nike from $64.00 to $68.00 and gave the stock an “outperform” rating in a report on Monday, September 28th. Cowen and Company raised their price objective on shares of Nike from $72.50 to $75.00 and gave the stock an “outperform” rating in a report on Monday, December 14th. Finally, Citigroup Inc. raised their price objective on shares of Nike from $63.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, September 25th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, twenty-eight have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $72.40.

In other Nike news, insider Jeanne P. Jackson sold 25,000 shares of Nike stock in a transaction on Monday, December 28th. The shares were sold at an average price of $63.58, for a total transaction of $1,589,500.00. Following the sale, the insider now owns 167,196 shares of the company’s stock, valued at approximately $10,630,321.68. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Timothy D. Cook sold 16,000 shares of Nike stock in a transaction on Tuesday, December 29th. The stock was sold at an average price of $64.04, for a total transaction of $1,024,640.00. Following the sale, the director now directly owns 12,682 shares in the company, valued at approximately $812,155.28. The disclosure for this sale can be found here.

12 Month Chart for NYSE:NKE

NIKE, Inc. is engaged in the design, development, marketing and selling of athletic footwear, apparel, equipment, accessories and services. The Company sells its products to retail accounts, through NIKE-owned retail stores and Internet Websites (NYSE:NKE), and through a mix of independent distributors and licensees throughout the world. The Company focuses its NIKE Brand product offerings in eight key categories: Running, Basketball, Football (Soccer), Men’s Training, Women’s Training, Action Sports, Sportswear (the Company’s sports-inspired lifestyle products) and Golf. The Company also markets products designed for kids, as well as for other athletic and recreational uses, such as cricket, lacrosse, tennis, volleyball, wrestling, walking and outdoor activities. The Company’s portfolio brands include the NIKE Brand, Jordan Brand, Hurley and Converse

Read More: http://investorshangout.com/post/view?id=3453...z3w6gADNQy
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 70

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 137

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 116

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 216

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 261

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 111

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 253

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 121

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading

Top 5 Most Recently Viewed Articles

Aethlon Medical Sets Upcoming Financial Call: What to Expect

Updated Category News Views 27

Aethlon Medical Announces Upcoming Financial Results Aethlon Medical, Inc. (NASDAQ: AEMD), a company dedicated to advancements in medical therapeutics, is preparing to release its financial results for the fiscal second quarter. This report will cover the period that concluded on September 30, with the official release set for a specific time on an upcoming Wednesday....

Continue Reading
Community Associations Institute Challenges Corporate Transparency Act

Updated Category News Views 63

Community Associations Institute Files for Preliminary Injunction Today, the United States District Court will hear a legal case involving the Community Associations Institute (CAI) regarding the Corporate Transparency Act. The proceedings are set to begin as CAI seeks to prevent the enforcement of this law against community associations. Understanding the Corporate...

Continue Reading
OMNIQ Corp. Prepares for Its Upcoming Virtual Conference

Updated Category News Views 54

OMNIQ Corp. Set to Showcase Innovations at Upcoming Event OMNIQ Corp. (OMQS), a front-runner in AI-machine vision and automation technology, has announced a significant opportunity for investors. Shai Lustgarten, the CEO of OMNIQ, will present at the Small Cap Virtual Investor Conference, an interactive platform designed for investors to engage directly with public...

Continue Reading
Revolutionizing Orthopedics: Exactech’s Innovative CT Analysis

Updated Category News Views 112

Revolutionizing Pre-Operative Planning with CT Radiomics Exactech, a leader in medical technology, recently introduced an impressive breakthrough in orthopedic surgery: the large-scale, fully automated CT radiomic analysis of shoulder bones and muscles. This pioneering study marks a significant advancement in personalized pre-operative planning for shoulder surgeries....

Continue Reading
Industrial Scientific Launches Advanced MPS LEL Sensor for Safety

Updated Category News Views 85

Industrial Scientific Introduces MPS LEL Sensor The new sensor for the Radius BZ1 enhances runtime, reliability, and the detection of various flammable gases. Significant Advancements in Gas Detection Industrial Scientific, a global leader in automation for safety workflows, has launched the latest generation of MPS™ LEL Sensors. These sensors are integral to their...

Continue Reading